Home » Topics » Disease categories and therapies » Dental

Dental
RSS

FDA grants fast track designation to SGX-942

June 4, 2013

Sosei initiates phase III study of mucoadhesive buccal tablet for oropharyngeal candidiasis

March 12, 2013

C3 Jian completes enrollment for phase I study of candidate for cavity prevention

Feb. 20, 2013

PolyMedix receives NCI grant to study brilacidin for oral mucositis

Sep. 20, 2012

Dara BioSciences acquires exclusive U.S. right to Gelclair

Sep. 17, 2012

ActoGeniX reports on phase I AG-013 trial

Aug. 23, 2012

IND cleared for phase I study of peptide to prevent dental caries

May 30, 2012

FDA approves first cell-based product made from allogeneic human cells and bovine collagen

March 14, 2012

Promising nanoparticle-based dental treatment developed in Germany

Jan. 25, 2012

BioMimetic obtains CE mark for growth factor-enhanced matrix

Jan. 4, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...